Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel.

Source:http://linkedlifedata.com/resource/pubmed/id/20492465

Download in:

View as

General Info

PMID
20492465